Listed

ALX Oncology Holdings Inc

ALXONasdaqCIK 1810182HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$18.0m, Q2 FY2026
Net income−$18.0m, Q2 FY2026
ALX Oncology Holdings Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m45.8Research and development, Q3 FY2023, three months to 2023-09-30$45.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123290.Report this figure41.8Research and development, Q4 FY2023, three months to 2023-12-31$41.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-09, accession 0001193125-26-098454. Derived: 12-month figure less the 9-month figure.Report this figure31.7Research and development, Q1 FY2024, three months to 2024-03-31$31.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066894.Report this figure34.7Research and development, Q2 FY2024, three months to 2024-06-30$34.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0000950170-25-107303.Report this figure26.5Research and development, Q3 FY2024, three months to 2024-09-30$26.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure23.5Research and development, Q4 FY2024, three months to 2024-12-31$23.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-09, accession 0001193125-26-098454. Derived: 12-month figure less the 9-month figure.Report this figure23.9Research and development, Q1 FY2025, three months to 2025-03-31$23.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure18.0Research and development, Q2 FY2025, three months to 2025-06-30$18.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure17.4Research and development, Q3 FY2025, three months to 2025-09-30$17.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure17.6Research and development, Q4 FY2025, three months to 2025-12-31$17.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-09, accession 0001193125-26-098454. Derived: 12-month figure less the 9-month figure.Report this figure13.6Research and development, Q1 FY2026, three months to 2026-03-31$13.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure13.1Research and development, Q2 FY2026, three months to 2026-06-30$13.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure
Operating income$m(53.3)Operating income, Q3 FY2023, three months to 2023-09-30−$53.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123290.Report this figure(48.0)Operating income, Q4 FY2023, three months to 2023-12-31−$48.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001193125-26-098454. Derived: 12-month figure less the 9-month figure.Report this figure(37.8)Operating income, Q1 FY2024, three months to 2024-03-31−$37.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066894.Report this figure(41.5)Operating income, Q2 FY2024, three months to 2024-06-30−$41.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0000950170-25-107303.Report this figure(32.6)Operating income, Q3 FY2024, three months to 2024-09-30−$32.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure(30.6)Operating income, Q4 FY2024, three months to 2024-12-31−$30.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001193125-26-098454. Derived: 12-month figure less the 9-month figure.Report this figure(31.8)Operating income, Q1 FY2025, three months to 2025-03-31−$31.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure(26.6)Operating income, Q2 FY2025, three months to 2025-06-30−$26.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure(22.5)Operating income, Q3 FY2025, three months to 2025-09-30−$22.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure(23.0)Operating income, Q4 FY2025, three months to 2025-12-31−$23.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001193125-26-098454. Derived: 12-month figure less the 9-month figure.Report this figure(19.0)Operating income, Q1 FY2026, three months to 2026-03-31−$19.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure(18.0)Operating income, Q2 FY2026, three months to 2026-06-30−$18.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure
Interest expense$m0.4Interest expense, Q3 FY2023, three months to 2023-09-30$391.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123290.Report this figure0.4Interest expense, Q4 FY2023, three months to 2023-12-31$415.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-09, accession 0001193125-26-098454. Derived: 12-month figure less the 9-month figure.Report this figure0.4Interest expense, Q1 FY2024, three months to 2024-03-31$427.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066894.Report this figure0.4Interest expense, Q2 FY2024, three months to 2024-06-30$429.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-12, accession 0000950170-25-107303.Report this figure0.4Interest expense, Q3 FY2024, three months to 2024-09-30$446.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure0.4Interest expense, Q4 FY2024, three months to 2024-12-31$427.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-09, accession 0001193125-26-098454. Derived: 12-month figure less the 9-month figure.Report this figure0.4Interest expense, Q1 FY2025, three months to 2025-03-31$406.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure0.4Interest expense, Q2 FY2025, three months to 2025-06-30$405.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure0.4Interest expense, Q3 FY2025, three months to 2025-09-30$408.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure0.4Interest expense, Q4 FY2025, three months to 2025-12-31$383.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-09, accession 0001193125-26-098454. Derived: 12-month figure less the 9-month figure.Report this figure0.3Interest expense, Q1 FY2026, three months to 2026-03-31$331.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure0.3Interest expense, Q2 FY2026, three months to 2026-06-30$285.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(51.0)Net income, Q3 FY2023, three months to 2023-09-30−$51.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123290.Report this figure(45.5)Net income, Q4 FY2023, three months to 2023-12-31−$45.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001193125-26-098454. Derived: 12-month figure less the 9-month figure.Report this figure(35.6)Net income, Q1 FY2024, three months to 2024-03-31−$35.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure(39.4)Net income, Q2 FY2024, three months to 2024-06-30−$39.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure(30.7)Net income, Q3 FY2024, three months to 2024-09-30−$30.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure(29.2)Net income, Q4 FY2024, three months to 2024-12-31−$29.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001193125-26-098454. Derived: 12-month figure less the 9-month figure.Report this figure(30.8)Net income, Q1 FY2025, three months to 2025-03-31−$30.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure(25.9)Net income, Q2 FY2025, three months to 2025-06-30−$25.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure(22.1)Net income, Q3 FY2025, three months to 2025-09-30−$22.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure(22.8)Net income, Q4 FY2025, three months to 2025-12-31−$22.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001193125-26-098454. Derived: 12-month figure less the 9-month figure.Report this figure(17.9)Net income, Q1 FY2026, three months to 2026-03-31−$17.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure(18.0)Net income, Q2 FY2026, three months to 2026-06-30−$18.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure
Diluted EPS$ per share(1.24)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$1.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-123290.Report this figurenot reported(0.71)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.71 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-066894.Report this figure(0.76)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.76 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0000950170-25-107303.Report this figure(0.58)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.58 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figurenot reported(0.58)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.58 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure(0.49)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure(0.41)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figurenot reported(0.17)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure(0.13)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure
Basic EPS$ per share(1.24)Basic EPS, Q3 FY2023, three months to 2023-09-30−$1.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-123290.Report this figurenot reported(0.71)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.71 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-066894.Report this figure(0.76)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.76 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0000950170-25-107303.Report this figure(0.58)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.58 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figurenot reported(0.58)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.58 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure(0.49)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure(0.41)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figurenot reported(0.17)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure(0.13)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure

Balance sheet

Cash and equivalents$22.7m, Q2 FY2026
Long-term debt$9.7m, Q2 FY2026
Shareholders' equity$136.2m, Q2 FY2026
ALX Oncology Holdings Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m19.6Cash and equivalents, Q3 FY2023, at 2023-09-30$19.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-123290.Report this figure22.4Cash and equivalents, FY2023, at 2023-12-31$22.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-09, accession 0001193125-26-098454.Report this figure14.0Cash and equivalents, Q1 FY2024, at 2024-03-31$14.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-066894.Report this figure15.5Cash and equivalents, Q2 FY2024, at 2024-06-30$15.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0000950170-25-107303.Report this figure16.1Cash and equivalents, Q3 FY2024, at 2024-09-30$16.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure17.6Cash and equivalents, FY2024, at 2024-12-31$17.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-09, accession 0001193125-26-098454.Report this figure20.6Cash and equivalents, Q1 FY2025, at 2025-03-31$20.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure19.3Cash and equivalents, Q2 FY2025, at 2025-06-30$19.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure23.4Cash and equivalents, Q3 FY2025, at 2025-09-30$23.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure16.4Cash and equivalents, FY2025, at 2025-12-31$16.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure32.3Cash and equivalents, Q1 FY2026, at 2026-03-31$32.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure22.7Cash and equivalents, Q2 FY2026, at 2026-06-30$22.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure
Current assets$m199Current assets, Q3 FY2023, at 2023-09-30$199.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0000950170-23-062929.Report this figure189Current assets, FY2023, at 2023-12-31$188.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-06, accession 0000950170-25-034761.Report this figure168Current assets, Q1 FY2024, at 2024-03-31$167.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056953.Report this figure169Current assets, Q2 FY2024, at 2024-06-30$168.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095391.Report this figure156Current assets, Q3 FY2024, at 2024-09-30$155.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123290.Report this figure134Current assets, FY2024, at 2024-12-31$134.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-09, accession 0001193125-26-098454.Report this figure103Current assets, Q1 FY2025, at 2025-03-31$102.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066894.Report this figure85.3Current assets, Q2 FY2025, at 2025-06-30$85.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107303.Report this figure66.5Current assets, Q3 FY2025, at 2025-09-30$66.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure50.7Current assets, FY2025, at 2025-12-31$50.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure146Current assets, Q1 FY2026, at 2026-03-31$145.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure143Current assets, Q2 FY2026, at 2026-06-30$143.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure
Total assets$m220Total assets, Q3 FY2023, at 2023-09-30$220.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0000950170-23-062929.Report this figure243Total assets, FY2023, at 2023-12-31$242.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-06, accession 0000950170-25-034761.Report this figure213Total assets, Q1 FY2024, at 2024-03-31$212.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000950170-24-056953.Report this figure215Total assets, Q2 FY2024, at 2024-06-30$214.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-12, accession 0000950170-24-095391.Report this figure186Total assets, Q3 FY2024, at 2024-09-30$185.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-123290.Report this figure148Total assets, FY2024, at 2024-12-31$147.8m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-09, accession 0001193125-26-098454.Report this figure121Total assets, Q1 FY2025, at 2025-03-31$120.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-066894.Report this figure95.3Total assets, Q2 FY2025, at 2025-06-30$95.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0000950170-25-107303.Report this figure82.7Total assets, Q3 FY2025, at 2025-09-30$82.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure59.0Total assets, FY2025, at 2025-12-31$59.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure178Total assets, Q1 FY2026, at 2026-03-31$178.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure161Total assets, Q2 FY2026, at 2026-06-30$160.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure
Current liabilities$m35.1Current liabilities, Q3 FY2023, at 2023-09-30$35.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0000950170-23-062929.Report this figure36.0Current liabilities, FY2023, at 2023-12-31$36.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-06, accession 0000950170-25-034761.Report this figure32.2Current liabilities, Q1 FY2024, at 2024-03-31$32.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056953.Report this figure38.4Current liabilities, Q2 FY2024, at 2024-06-30$38.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095391.Report this figure32.3Current liabilities, Q3 FY2024, at 2024-09-30$32.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123290.Report this figure18.5Current liabilities, FY2024, at 2024-12-31$18.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-09, accession 0001193125-26-098454.Report this figure18.7Current liabilities, Q1 FY2025, at 2025-03-31$18.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066894.Report this figure18.8Current liabilities, Q2 FY2025, at 2025-06-30$18.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107303.Report this figure27.7Current liabilities, Q3 FY2025, at 2025-09-30$27.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure24.6Current liabilities, FY2025, at 2025-12-31$24.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure20.2Current liabilities, Q1 FY2026, at 2026-03-31$20.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure14.8Current liabilities, Q2 FY2026, at 2026-06-30$14.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure
Total liabilities$m51.4Total liabilities, Q3 FY2023, at 2023-09-30$51.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0000950170-23-062929.Report this figure52.8Total liabilities, FY2023, at 2023-12-31$52.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-06, accession 0000950170-25-034761.Report this figure48.5Total liabilities, Q1 FY2024, at 2024-03-31$48.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0000950170-24-056953.Report this figure55.3Total liabilities, Q2 FY2024, at 2024-06-30$55.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-12, accession 0000950170-24-095391.Report this figure48.9Total liabilities, Q3 FY2024, at 2024-09-30$48.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-123290.Report this figure34.2Total liabilities, FY2024, at 2024-12-31$34.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-09, accession 0001193125-26-098454.Report this figure32.6Total liabilities, Q1 FY2025, at 2025-03-31$32.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-066894.Report this figure30.9Total liabilities, Q2 FY2025, at 2025-06-30$30.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0000950170-25-107303.Report this figure37.9Total liabilities, Q3 FY2025, at 2025-09-30$37.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure33.1Total liabilities, FY2025, at 2025-12-31$33.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure27.0Total liabilities, Q1 FY2026, at 2026-03-31$27.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure24.6Total liabilities, Q2 FY2026, at 2026-06-30$24.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure
Long-term debt$m9.6Long-term debt, Q3 FY2023, at 2023-09-30$9.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-13, accession 0000950170-23-062929.Report this figure9.6Long-term debt, FY2023, at 2023-12-31$9.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-06, accession 0000950170-25-034761.Report this figure9.7Long-term debt, Q1 FY2024, at 2024-03-31$9.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056953.Report this figure9.8Long-term debt, Q2 FY2024, at 2024-06-30$9.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095391.Report this figure9.8Long-term debt, Q3 FY2024, at 2024-09-30$9.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123290.Report this figure9.5Long-term debt, FY2024, at 2024-12-31$9.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-09, accession 0001193125-26-098454.Report this figure8.2Long-term debt, Q1 FY2025, at 2025-03-31$8.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066894.Report this figure7.0Long-term debt, Q2 FY2025, at 2025-06-30$7.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107303.Report this figure5.8Long-term debt, Q3 FY2025, at 2025-09-30$5.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure4.5Long-term debt, FY2025, at 2025-12-31$4.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure3.3Long-term debt, Q1 FY2026, at 2026-03-31$3.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure9.7Long-term debt, Q2 FY2026, at 2026-06-30$9.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure
Current portion of debt$m0.0Current portion of debt, Q3 FY2023, at 2023-09-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-13, accession 0000950170-23-062929.Report this figure0.0Current portion of debt, FY2023, at 2023-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2024-03-07, accession 0000950170-24-027955.Report this figure0.0Current portion of debt, Q1 FY2024, at 2024-03-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056953.Report this figure0.0Current portion of debt, Q2 FY2024, at 2024-06-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095391.Report this figure0.0Current portion of debt, Q3 FY2024, at 2024-09-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123290.Report this figure0.4Current portion of debt, FY2024, at 2024-12-31$435.0k. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-03-09, accession 0001193125-26-098454.Report this figure1.7Current portion of debt, Q1 FY2025, at 2025-03-31$1.7m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066894.Report this figure3.0Current portion of debt, Q2 FY2025, at 2025-06-30$3.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107303.Report this figure4.3Current portion of debt, Q3 FY2025, at 2025-09-30$4.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure5.2Current portion of debt, FY2025, at 2025-12-31$5.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure5.2Current portion of debt, Q1 FY2026, at 2026-03-31$5.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure0.0Current portion of debt, Q2 FY2026, at 2026-06-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure
Shareholders' equity$m169Shareholders' equity, Q3 FY2023, at 2023-09-30$168.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-123290.Report this figure190Shareholders' equity, FY2023, at 2023-12-31$189.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-09, accession 0001193125-26-098454.Report this figure164Shareholders' equity, Q1 FY2024, at 2024-03-31$164.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure159Shareholders' equity, Q2 FY2024, at 2024-06-30$159.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure137Shareholders' equity, Q3 FY2024, at 2024-09-30$136.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure114Shareholders' equity, FY2024, at 2024-12-31$113.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure88.3Shareholders' equity, Q1 FY2025, at 2025-03-31$88.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure64.4Shareholders' equity, Q2 FY2025, at 2025-06-30$64.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure44.8Shareholders' equity, Q3 FY2025, at 2025-09-30$44.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure26.0Shareholders' equity, FY2025, at 2025-12-31$26.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure151Shareholders' equity, Q1 FY2026, at 2026-03-31$151.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure136Shareholders' equity, Q2 FY2026, at 2026-06-30$136.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure

Cash flow

Operating cash flow−$16.1m, Q2 FY2026
Capital expenditure$17.0k, Q2 FY2026
ALX Oncology Holdings Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(31.2)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$31.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-123290. Derived: 9-month figure less the 6-month figure.Report this figure(39.7)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$39.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001193125-26-098454. Derived: 12-month figure less the 9-month figure.Report this figure(37.9)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$37.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-066894.Report this figure(26.6)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$26.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0000950170-25-107303. Derived: 6-month figure less the 3-month figure.Report this figure(25.4)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$25.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001193125-25-272281. Derived: 9-month figure less the 6-month figure.Report this figure(32.0)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$32.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001193125-26-098454. Derived: 12-month figure less the 9-month figure.Report this figure(24.7)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$24.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure(23.4)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$23.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-337920. Derived: 6-month figure less the 3-month figure.Report this figure(17.1)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$17.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001193125-25-272281. Derived: 9-month figure less the 6-month figure.Report this figure(19.0)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$19.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001193125-26-098454. Derived: 12-month figure less the 9-month figure.Report this figure(18.6)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$18.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure(16.1)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$16.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-337920. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m(1.3)Capital expenditure, Q3 FY2023, three months to 2023-09-30−$1.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-123290. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$148.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-09, accession 0001193125-26-098454. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$148.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0000950170-25-066894.Report this figure0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$90.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0000950170-25-107303. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$149.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001193125-25-272281. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$60.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-09, accession 0001193125-26-098454. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$60.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$47.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-337920. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$56.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001193125-25-272281. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$49.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-09, accession 0001193125-26-098454. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$50.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$17.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-337920. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)135.64m, Q2 FY2026
ALX Oncology Holdings Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares40.7Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3040,747,026 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0000950170-23-062929.Report this figure40.9Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3140,862,513 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0000950170-24-056953.Report this figure40.9Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3040,875,457 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-12, accession 0000950170-24-095391.Report this figure41.1Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3041,147,938 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-123290.Report this figure50.1Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3150,120,758 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-066894.Report this figure51.8Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3051,831,157 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0000950170-25-107303.Report this figure52.7Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3052,693,878 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure53.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3153,359,338 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure53.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3053,445,631 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure53.6Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3053,577,066 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001193125-25-272281.Report this figure105Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31104,573,657 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001193125-26-213399.Report this figure136Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30135,639,684 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure

Shares outstanding: 138.28mShares outstanding, period not labelled, at 2026-07-30138,276,997 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-337920.Report this figure at Jul 30, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.